CARLSBAD, Calif., Feb 26, 2008 -- Patriot Scientific (OTCBB:PTSC) today announced that Advanced Medical Optics, Inc. (AMO) has purchased a Moore Microprocessor Patent(TM) (MMP) Portfolio license from The TPL Group, Patriot Scientific's licensing partner. AMO is engaged in the development, manufacture and marketing of medical devices for the eye, including diagnostic instruments as well as products used in ocular surgery and laser vision correction.
"AMO is dedicated to improving the quality of vision for others through a full range of advanced refractive technologies," said Carl Silverman, vice president of licensing for Alliacense. "We are pleased that AMO has joined the rapidly growing list of MMP Portfolio licensees."
The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world's leading manufacturers of end-user products from around the globe to become MMP Portfolio licensees. More than 40 global companies from the U.S., Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio technologies.
About Patriot Scientific
Patriot Scientific is a leading intellectual-property licensing company that develops, markets, and enables innovative technologies that satisfy the demands of fast-growing markets for wireless devices, smart cards, home appliances, network gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices, industrial controllers and more. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.ptsc.com.
An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/ptscprofile.aspx. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com. To receive free e-mail notification of future releases for Patriot Scientific, sign up at http://www.hawkassociates.com/email.aspx.
About Advanced Medical Optics
AMO is focused on providing the full range of advanced refractive technologies and support to help eye care professionals deliver optimal vision and lifestyle experiences to patients of all ages. Products in the laser vision correction line include wavefront diagnostic devices, femtosecond lasers and associated patient interface devices, and excimer laser vision correction systems. AMO also supplies a full line of contact lens care products, as well as products used in cataract/implant procedures. AMO is based in Santa Ana, California, and employs over 4,000 worldwide. The company has operations in more than 20 countries and markets products in approximately 60 countries. For more information, visit the company's website at http://www.amo-inc.com.
About the MMP Portfolio
The Moore Microprocessor Patent (MMP) Portfolio contains intellectual property that is jointly owned by the privately held TPL Group and publicly held Patriot Scientific Corporation (OTCBB:PTSC). The portfolio includes seven U.S. patents as well as their European and Japanese counterparts. It is becoming widely recognized that these patents protect fundamental technology used in designing microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors and system-on-chip (SoC) devices. The MMP portfolio is exclusively managed by Alliacense, a TPL Group Enterprise.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.
Moore Microprocessor Patent (MMP) and Alliacense are trademarks of Technology Properties Limited (TPL). PTSC is a trademark of Patriot Scientific Corporation. All other trademarks belong to their respective owners.
For Patriot Scientific, CarlsbadMedia Relations
The Hoffman Agency
John Radewagen, Vice President, Corporate Communications
408-975-3005
408-219-9199 (mobile)
jradewagen@hoffman.comhttp
www.hofman.com
Or
Patriot Scientific Investor
RelationsHawk Associates
Frank Hawkins or Ken AuYeung,
305-451-1888
info@hawkassociates.com
or
TPL / Alliacense
Shawn Clark,
408-446-4222
shawnc@tplgroup.net
